Lrrk2 modulation of Wnt signaling during zebrafish development

Jinelle M Wint1, Howard I Sirotkin2

  • 1Molecular and Cellular Biology Graduate Program, Stony Brook University, Stony Brook, NY, USA.

Insights

Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) scaffolding functions are crucial for Wnt signaling during development. Zebrafish models reveal LRRK2's role in promoting Wnt pathway activation, particularly when its scaffolding domains are intact.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Mutations in leucine-rich repeat kinase 2 (LRRK2) are a leading genetic cause of Parkinson's disease.
  • The precise pathogenic mechanisms of LRRK2 variants are complex due to LRRK2's multifaceted cellular roles.

Purpose of the Study:

  • To investigate the developmental roles of LRRK2 using a zebrafish allelic series.
  • To dissect the functional importance of LRRK2's distinct domains (GTPase, kinase, scaffolding) in cellular processes.

Main Methods:

  • Generation of zebrafish lrrk2 mutants lacking specific functional domains.
  • Assessment of Wnt signaling using whole mount RNA in situ hybridization and a transgenic Wnt reporter.
  • Analysis of Wnt target gene expression in mutant lines.

Main Results:

  • All generated lrrk2 mutant zebrafish lines were viable and exhibited normal morphology and locomotion.
  • While Wnt signaling domains were generally preserved, Wnt pathway activation was attenuated in the lrrk2 mutant lacking both scaffolding and catalytic domains (lrrk2sbu304/sbu304).
  • This attenuation was not observed in mutants lacking only the GTPase/kinase or only the kinase domain.

Conclusions:

  • LRRK2's scaffolding functions, rather than its catalytic kinase activity, appear critical for promoting canonical Wnt signaling in a context-dependent manner during zebrafish embryogenesis.
  • These findings provide insights into the complex role of LRRK2 in both Parkinson's disease pathogenesis and normal developmental signaling pathways.